Pfizer’s financial projections illustrate the company’s near-term challenges. Revenue estimates show a declining trajectory, with fiscal year 2025 expected to generate $62.7 billion, down from $63.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results